NextCure (NXTC) EPS (Diluted) (2019 - 2026)
NextCure (NXTC) EPS (Diluted) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 4.31 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 12.23 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 7.33 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.05 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.19 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.15 |
| 10 | NextCure | 33.72 Mn | 33.72 Mn | - | -2.84 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.86 |
| Mar 31, 2026 | -3.03 |
| Dec 31, 2025 | -3.44 |
| Sep 30, 2025 | -5.72 |
| Jun 30, 2025 | -14.31 |
| Mar 31, 2025 | -5.10 |
| Dec 31, 2024 | -5.82 |
| Sep 30, 2024 | -5.90 |
| Jun 30, 2024 | -10.39 |
| Mar 31, 2024 | -7.97 |
| Dec 31, 2023 | -6.65 |
| Sep 30, 2023 | -10.33 |
| Jun 30, 2023 | -12.16 |
| Mar 31, 2023 | -7.18 |
| Dec 31, 2022 | -7.66 |
| Sep 30, 2022 | -9.38 |
| Jun 30, 2022 | -8.91 |
| Mar 31, 2022 | -10.62 |
| Dec 31, 2021 | -7.66 |
| Sep 30, 2021 | -9.58 |